Teva Gains Another $2.48 Billion For Selling The Last Of Its Women???s Health Portfolio Post author:Sam Post published:September 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Approves 23andMe’s Direct-to-Consumer Genetic Test for Cancer March 6, 2018 Heron Therapeutics Soars on Positive Phase III Results March 18, 2018 Trump's CDC Director Resigns Over Pharma, Tobacco Investments January 31, 2018